A pharmaceutical composition for fighting lung cancer and preparation method thereof
By combining a variety of traditional Chinese medicines for decoction, fermentation and microencapsulation, an anti-lung cancer drug composition was prepared, which solved the problems of single ingredients and low purity in the prior art, significantly improved the efficacy of anti-lung cancer and the use of drugs. Effect.
Patent Information
- Application Number
- CN202410583207.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-05-11
- Publication Date
- 2024-11-01
- Estimated Expiration
- 2044-05-11
AI Technical Summary
The existing anti-lung cancer drug composition has a single ingredients, and the purity and active ingredient content of Chonglou extract are poor, resulting in limited effect and inability to achieve positive anti-lung cancer effect.
A pharmaceutical composition for anti-lung cancer is adopted, consisting of sausage, sausage, sausage, sausage, sausage, sausage, sausage, sausage, sausage, sausage, sausage, sausage, sausage, sausage, sausage, sausage, sausage, sausage, sausage, sausage, sausage, sausage, sausage, sausage, sausage, sausage, sausage The Chinese medicine is composed of other Chinese medicines. Through decoction, filtration, fermentation and microencapsulation, a Chinese medicine extract and microcapsule with highly effective active ingredients are prepared to form a pharmaceutical composition that nourishes the kidneys and clears the lungs, clears heat and disperses the nodules and fights cancer.
It improves the release and shelf life of active ingredients of traditional Chinese medicine, reduces the bitterness of traditional Chinese medicine, achieves better medical effects, significantly improves the anti-lung cancer efficacy, improves the quality of life of patients and prolongs survival.
Smart Images

Figure SMS_1 
Figure SMS_2
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of traditional Chinese medicine compositions, in particular to a pharmaceutical composition for combating lung cancer and a preparation method thereof. Background Art
[0002] Lung cancer is one of the most common malignant tumors in the world today. Its incidence and mortality rate have ranked first among common tumors, making it a major killer of human health. In recent years, the incidence and mortality of lung cancer have been on the rise worldwide, increasing at a rate of 0.5% per year. Although radiotherapy and chemotherapy can kill cancer cells, they also damage normal tissues and have significant toxic side effects. Traditional Chinese medicine (including single herbs and compound Chinese medicines) has unique advantages and broad application prospects in anti-tumor toxicity reduction and efficacy enhancement. It not only improves the efficacy of treating middle and late stage lung cancer and insensitive non-small cell lung cancer, but also has few side effects. When combined with surgery, radiotherapy, chemotherapy and other treatments, it can enhance anti-cancer effects, reduce side effects, improve quality of life, and prolong survival. Therefore, traditional Chinese medicine plays an increasingly important role in tumor prevention and treatment.
[0003] For example, the invention patent with announcement number CN109010569A discloses a pharmaceutical composition with anti-lung cancer effect and a preparation method thereof. The pharmaceutical composition comprises a Paris polyphylla extract and Paris polyphylla saponin VII. The Paris polyphylla extract and Paris polyphylla saponin VII are mixed in a mass ratio of 5-20:1 to obtain a pharmaceutical composition. The pharmaceutical composition has high activity and clear effects, and can be prepared into a clinical dosage preparation with clinically accepted excipients. However, the anti-lung cancer pharmaceutical composition has a single component, and during the preparation process, the purity and active ingredient content of the Paris polyphylla extract are poor, resulting in limited effects, and failing to achieve a particularly positive effect on lung cancer. Summary of the Invention
[0004] In view of the problems existing in the prior art, the present invention aims to provide a pharmaceutical composition for treating lung cancer and a preparation method thereof.
[0005] To achieve the above object, the present invention provides the following technical solutions:
[0006] A pharmaceutical composition for treating lung cancer is prepared from the following raw materials in parts by weight: 10-15 parts of Prunella Vulgaris, 5-10 parts of Hedyotis diffusa, 5-10 parts of Agrimoniae, 10-18 parts of Cornus officinalis, 3-7 parts of Rutaceae, 2-6 parts of Solanum nigrum, 5-10 parts of Elsholtzia ciliata, 5-10 parts of Scutellaria baicalensis seeds, 3-6 parts of Scutellaria barbata, 2-8 parts of Astragalus membranaceus, 1-3 parts of Cordyceps sinensis, 1-5 parts of Codonopsis pilosula, 2-10 parts of Atractylodes macrocephala, and 3-8 parts of Pinellia ternata.
[0007] As a further preferred embodiment of the present invention, the pharmaceutical composition comprises a Chinese medicine extract and Chinese medicine microcapsules;
[0008] The content of the Chinese medicine microcapsules is 5-10% of the total mass of the Chinese medicine extract;
[0009] The traditional Chinese medicine extract is obtained by decocting and filtering Elsholtzia ciliata, Scutellaria barbata, Astragalus membranaceus, Cordyceps sinensis, Codonopsis pilosula, Atractylodes macrocephala and Pinellia ternata.
[0010] As a further preferred embodiment of the present invention, the preparation method of the Chinese medicine microcapsules is as follows:
[0011] 1) Mix 200-300 g of Chinese medicine, 4-9 mL of fermentation liquid of Chinese medicine strain, and 91-96 mL of water evenly, stir, put into a breathing bag, compact, and perform anaerobic fermentation of raw material in an incubator at 37-39°C for 72-80 hours. After the fermentation is completed, sterilize the fermented material at 121-123°C for 15-20 minutes and set aside;
[0012] 2) The fermented product is centrifuged and filtered, and the filtrate is concentrated to a relative density of 1.1-1.3. Anhydrous ethanol is added, and the volume content of anhydrous ethanol is maintained at 80-90%, and then the product is extracted by reflux in a water bath. After the reflux is completed, the product is repeatedly rinsed with anhydrous ethanol, and anhydrous ethanol is added to the filtrate, and the volume content of anhydrous ethanol is maintained at 80-90%, and the product is extracted by reflux in a water bath again;
[0013] 3) Place the precipitates obtained from the two extractions into a container, add 100-180 mL of purified water, reflux in a water bath for 40-60 minutes, remove and cool to room temperature, centrifuge at 5000-8000 rpm for 10-20 minutes, and collect the supernatant to obtain the traditional Chinese medicine solution;
[0014] 4) Gelatin and sodium carboxymethyl cellulose are dissolved in ultrapure water and stirred in a water bath at 60-70°C for 2-3 hours. The mixture is centrifuged at 8000-12000 r / min and 4-6°C for 20-30 minutes to obtain a polymer wall material solution. The Chinese medicine solution is added to the polymer wall material solution at a core-wall mass ratio of 1:(4-5). 2-4% of the total mass of the polymer wall material solution is added with p-nitrophenyl palmitate. The pH value is adjusted to 4.0-4.5 with a 5-10wt% acetic acid solution. After magnetic stirring for 30-50 minutes, the pH value is adjusted to 6.0-6.5 with a 10-15wt% sodium hydroxide solution. Glutamine transaminase is added for solidification at 4-6°C for 1-3 hours. The mixture is freeze-dried in a vacuum and crushed to obtain Chinese medicine microcapsules.
[0015] As a further preferred embodiment of the present invention, in step 1), the Chinese medicine is composed of Prunella Vulgaris, Hedyotis diffusa, Agrimoniae, Cornus officinalis, Rutaecarpa ovata, and Solanum nigrum in parts by weight.
[0016] As a further preferred embodiment of the present invention, in step 2), the extraction time of the water bath reflux extraction is 50-70 minutes.
[0017] As a further preferred embodiment of the present invention, in step 4), the mass ratio of gelatin to sodium carboxymethyl cellulose is 1:(1-2);
[0018] The concentration of the composite wall material solution is 0.5-1.5 wt %.
[0019] As a further preferred embodiment of the present invention, the method for cultivating the Chinese medicinal strain fermentation broth is as follows:
[0020] 1) Weigh a compound Chinese herbal medicine consisting of Prunella Vulgaris, Hedyotis Diffusa, Agrimoniae, Cornus officinalis, Rutaceae, and Solanum nigrum, add 5-8 times the weight of distilled water of the compound Chinese herbal medicine, decoct for 1-2 hours, and filter to obtain a medicinal solution. Add 5-8 times the weight of distilled water to the medicinal residue, continue decoction for 1-2 hours, and filter to obtain a medicinal solution. Combine the two medicinal solutions, filter, and concentrate in an oven to dry to obtain a Chinese herbal concentrate.
[0021] 2) Add the Chinese medicine concentrate to the MRS liquid culture medium at a rate of 2-3 wt% based on the mass of the liquid culture medium, mix thoroughly to obtain the Chinese medicine culture medium, then activate the Lactobacillus plantarum at an inoculum rate of 2-3%, inoculate the activated Lactobacillus plantarum into the Chinese medicine culture medium under sterile conditions, and cultivate for 24-30 hours to obtain the Chinese medicine fermentation liquid.
[0022] As a further preferred embodiment of the present invention, in step 1), the temperature of the oven is 75-78°C.
[0023] As a further preferred embodiment of the present invention, in step 2), the incubation is carried out at 37-39°C.
[0024] A method for preparing a pharmaceutical composition for treating lung cancer comprises the following steps:
[0025] According to weight, licorice root, sky blueberry seed, Scutellaria barbata, astragalus, cordyceps, codonopsis pilosula, atractylodes macrocephala, and pinellia are mixed and crushed, decocted with water, and the decoction is filtered. The filtrate is concentrated to a concentrate with a relative density of 1.2-1.4, refrigerated and then centrifuged. The supernatant is taken, and Chinese medicine microcapsules are added. After fully mixing, a pharmaceutical composition is obtained.
[0026] Compared with the prior art, the present invention has the following beneficial effects:
[0027] In the present invention, a compound Chinese medicine composed of Prunella vulgaris, Hedyotis diffusa, Agrimony Root, Cornus officinalis, Rutaecarpa and Solanum nigrum is decocted and filtered to obtain a Chinese medicine concentrate, and then the Chinese medicine concentrate is added to an MRS liquid culture medium to obtain a Chinese medicine culture medium, and then the special culture medium is used to culture plant lactobacillus to achieve the purpose of screening, thereby obtaining a special strain with a high-efficiency fermentation effect on the above-mentioned Chinese medicine, which can significantly enhance the subsequent fermentation; and then the Chinese medicine composed of Prunella vulgaris, Hedyotis diffusa, Agrimony Root, Cornus officinalis, Rutaecarpa and Solanum nigrum is fermented with the Chinese medicine strain fermentation liquid, and the special strain obtained through screening can achieve a high-efficiency fermentation effect on the Chinese medicine. , promoting the full release of active ingredients in traditional Chinese medicine, so that the fermentation contains a high content of active ingredients of traditional Chinese medicine, which has better medical effects, and then the fermentation is centrifuged and filtered and then precipitated with alcohol to obtain traditional Chinese medicine liquid, and gelatin-carboxymethyl cellulose is selected to form a composite wall material, and the traditional Chinese medicine liquid is used as the core material. After vacuum freeze-drying, traditional Chinese medicine microcapsules are obtained. By microencapsulating traditional Chinese medicine, the active ingredients of traditional Chinese medicine can be isolated from the external environment. On the one hand, it can reduce and mask the unique bitterness of traditional Chinese medicine, and at the same time it also helps to extend the shelf life and control the release of the encapsulated core material, thereby achieving sustainable release of the core material of the encapsulation material, thereby achieving better medical effects.
[0028] In the present invention, a part of the traditional Chinese medicine is fermented, encapsulated, and then mixed with the traditional Chinese medicine extract obtained by decocting and filtering the remaining traditional Chinese medicine to obtain a pharmaceutical composition. The pharmaceutical composition has the effects of nourishing the kidney and clearing the lung, clearing away heat, dispersing stagnation and anti-cancer. At the same time, it has been proven to have good therapeutic effects in clinical applications. It can not only improve symptoms and improve the quality of life of patients, but also reduce recurrence and prolong the survival of patients. DETAILED DESCRIPTION
[0029] The following is a clear and complete description of the technical solutions in the embodiments of the present invention. Obviously, the embodiments described are only some embodiments of the present invention, not all embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without making any creative efforts are within the scope of protection of the present invention. Example 1
[0030] A pharmaceutical composition for treating lung cancer, the pharmaceutical composition being prepared from the following raw materials in parts by weight: 10 parts of Prunella Vulgaris, 5 parts of Hedyotis diffusa, 5 parts of Agrimoniae, 10 parts of Cornus officinalis, 3 parts of Rutaceae, 2 parts of Solanum nigrum, 5 parts of Elsholtzia ciliata, 5 parts of Scutellaria baicalensis, 3 parts of Scutellaria barbata, 2 parts of Astragalus membranaceus, 1 part of Cordyceps sinensis, 1 part of Codonopsis pilosula, 2 parts of Atractylodes macrocephala, and 3 parts of Pinellia ternata;
[0031] The pharmaceutical composition comprises a traditional Chinese medicine extract and traditional Chinese medicine microcapsules;
[0032] The content of Chinese medicine microcapsules is 5% of the total mass of the Chinese medicine extract;
[0033] The Chinese medicine extract is obtained by decocting and filtering Elsholtzia ciliata, Scutellaria barbata, Astragalus membranaceus, Cordyceps sinensis, Codonopsis pilosula, Atractylodes macrocephala and Pinellia ternata;
[0034] The specific steps include:
[0035] According to weight, the herb Elsholtzia ciliata, the seed of Gastrodia elata, the herb Scutellaria barbata, the root of Astragalus membranaceus, the herb Cordyceps sinensis, the herb Codonopsis pilosula, the herb Atractylodes macrocephala, and the herb Pinellia ternata are mixed and crushed, and then decocted with water. The decoction is then filtered and the filtrate is concentrated to a concentrate with a relative density of 1.2. The mixture is refrigerated and centrifuged, and the supernatant is taken and added with Chinese medicine microcapsules. The mixture is thoroughly mixed to obtain a pharmaceutical composition.
[0036] The preparation method of Chinese medicine microcapsules is as follows:
[0037] 1) Weigh a Chinese herbal compound consisting of Prunella Vulgaris, Hedyotis Diffusa, Agrimoniae, Cornus officinalis, Rutaceae, and Solanum nigrum. Add 5 times the weight of distilled water to the compound, boil for 1 hour, and filter to obtain a medicinal solution. Add 5 times the weight of distilled water to the medicinal residue, continue boiling for 1 hour, and filter to obtain a medicinal solution. Combine the two medicinal solutions, filter, and concentrate in a 75°C oven to dry to obtain a Chinese herbal concentrate.
[0038] 2) Adding the Chinese herbal medicine concentrate to the MRS liquid medium at a rate of 2 wt% based on the mass of the liquid medium, mixing thoroughly to obtain a Chinese herbal medicine culture medium, and then activating Lactobacillus plantarum at an inoculum rate of 2% and inoculating the activated Lactobacillus plantarum into the Chinese herbal medicine culture medium under sterile conditions. The culture is then incubated at 37°C for 24 hours to obtain a Chinese herbal medicine fermentation broth.
[0039] 3) Mix 200 g of Chinese medicine, 4 mL of fermentation liquid of Chinese medicine strain, and 91 mL of water, stir and place in a breathing bag, compact and perform anaerobic fermentation of raw material in an incubator at 37°C for 72 hours. After the fermentation is completed, sterilize the fermented material at 121°C for 15 minutes and set aside.
[0040] The Chinese medicine is composed of Prunella Vulgaris, Hedyotis diffusa, Agrimony Root, Cornus officinalis, Rutaecarpa, and Solanum nigrum according to parts by weight;
[0041] 4) The fermented product was centrifuged and filtered, and the filtrate was concentrated to a relative density of 1.1. Anhydrous ethanol was added, and the volume content of anhydrous ethanol was maintained at 80%. Then, water bath reflux extraction was performed for 50 minutes. After the reflux was completed, the product was repeatedly rinsed with anhydrous ethanol. Anhydrous ethanol was then added to the filtrate, and the volume content of anhydrous ethanol was maintained at 80%. Then, water bath reflux extraction was performed again for 50 minutes.
[0042] 5) Place the precipitates obtained from the two reactions in a container, add 100 mL of purified water, reflux in a water bath for 40 minutes, remove and cool to room temperature, centrifuge at 5000 rpm for 10 minutes, and collect the supernatant to obtain the Chinese medicine solution;
[0043] 6) Gelatin and sodium carboxymethyl cellulose were dissolved in ultrapure water and stirred in a 60°C water bath for 2 hours. The mixture was centrifuged at 8000 rpm and 4°C for 20 minutes. The mass ratio of gelatin to sodium carboxymethyl cellulose was 1:1 to obtain a 0.5 wt% polymer wall material solution. The Chinese medicine solution was added to the polymer wall material solution at a core-wall mass ratio of 1:4. 2% of the total mass of the polymer wall material solution was added with p-nitrophenyl palmitate, and the pH value was adjusted to 4.0 with a 5 wt% acetic acid solution. After magnetic stirring for 30 minutes, the pH value was adjusted to 6.0 with a 10 wt% sodium hydroxide solution. Glutamine transaminase was added for solidification at 4°C for 1 hour. The mixture was freeze-dried in a vacuum and crushed to obtain Chinese medicine microcapsules. Example 2
[0044] A pharmaceutical composition for treating lung cancer, the pharmaceutical composition being prepared from the following raw materials in parts by weight: 12 parts of Prunella Vulgaris, 7 parts of Hedyotis diffusa, 7 parts of Agrimoniae, 15 parts of Cornus officinalis, 5 parts of Rutaceae, 4 parts of Solanum nigrum, 7 parts of Elsholtzia ciliata, 7 parts of Scutellaria baicalensis, 5 parts of Scutellaria barbata, 5 parts of Astragalus, 2 parts of Cordyceps sinensis, 3 parts of Codonopsis pilosula, 6 parts of Atractylodes macrocephala, and 5 parts of Pinellia ternata;
[0045] The pharmaceutical composition comprises a traditional Chinese medicine extract and traditional Chinese medicine microcapsules;
[0046] The content of Chinese medicine microcapsules is 7% of the total mass of the Chinese medicine extract;
[0047] The Chinese medicine extract is obtained by decocting and filtering Elsholtzia ciliata, Scutellaria barbata, Astragalus membranaceus, Cordyceps sinensis, Codonopsis pilosula, Atractylodes macrocephala and Pinellia ternata;
[0048] The specific steps include:
[0049] According to weight, the herb Elsholtzia ciliata, the seed of Gastrodia elata, the herb Scutellaria barbata, the root of Astragalus membranaceus, the cordyceps sinensis, the codonopsis pilosula, the atractylodes macrocephala, and the pinellia tuber are mixed and crushed, and then decocted with water. The decoction is then filtered and the filtrate is concentrated to a concentrate with a relative density of 1.3. The mixture is refrigerated and then centrifuged. The supernatant is taken and Chinese medicine microcapsules are added. The mixture is thoroughly mixed to obtain a pharmaceutical composition.
[0050] The preparation method of Chinese medicine microcapsules is as follows:
[0051] 1) Weigh a compound Chinese herbal medicine consisting of Prunella Vulgaris, Hedyotis Diffusa, Agrimoniae, Cornus officinalis, Rutaceae, and Solanum nigrum. Add 7 times the weight of distilled water to the compound Chinese herbal medicine, decoct for 1.5 hours, and filter to obtain a medicinal solution. Add 7 times the weight of distilled water to the medicinal residue, continue decoction for 1.5 hours, and filter to obtain a medicinal solution. Combine the two medicinal solutions, filter, and concentrate in a 75-78°C oven to dry to obtain a Chinese herbal concentrate.
[0052] 2) Adding the Chinese herbal medicine concentrate to the MRS liquid medium at a rate of 2.5 wt% based on the mass of the liquid medium, mixing thoroughly to obtain a Chinese herbal medicine culture medium, and then activating Lactobacillus plantarum at an inoculum rate of 2.5%, inoculating the activated Lactobacillus plantarum into the Chinese herbal medicine culture medium under sterile conditions, and incubating the culture at 38°C for 26 hours to obtain a Chinese herbal medicine fermentation broth;
[0053] 3) Mix 250 g of Chinese medicine, 7 mL of fermentation liquid of Chinese medicine strain, and 93 mL of water, stir and place in a breathing bag, compact and perform anaerobic fermentation of raw material in an incubator at 38°C for 75 hours. After fermentation, sterilize the fermented material at 122°C for 18 minutes and set aside.
[0054] The Chinese medicine is composed of Prunella Vulgaris, Hedyotis diffusa, Agrimony Root, Cornus officinalis, Rutaecarpa, and Solanum nigrum according to parts by weight;
[0055] 4) The fermented product was centrifuged and filtered, and the filtrate was concentrated to a relative density of 1.2. Anhydrous ethanol was added, and the volume content of anhydrous ethanol was maintained at 85%. The product was then subjected to water bath reflux extraction for 60 minutes. After the reflux was completed, the product was repeatedly rinsed with anhydrous ethanol. Anhydrous ethanol was then added to the filtrate, and the volume content of anhydrous ethanol was maintained at 85%. The product was then subjected to water bath reflux extraction for another 60 minutes.
[0056] 5) Place the precipitates obtained from the two reactions in a container, add 150 mL of purified water, reflux in a water bath for 50 minutes, remove and cool to room temperature, centrifuge at 7000 rpm for 15 minutes, and collect the supernatant to obtain the Chinese medicine solution;
[0057] 6) Gelatin and sodium carboxymethyl cellulose were dissolved in ultrapure water and stirred in a 65°C water bath for 2.5 hours. The mixture was centrifuged at 10,000 rpm and 5°C for 25 minutes. The mass ratio of gelatin to sodium carboxymethyl cellulose was 1:1.5, and a 1 wt% polymer wall material solution was obtained. The Chinese medicine solution was added to the polymer wall material solution according to a core-wall mass ratio of 1:4.5. 3% of the total mass of the polymer wall material solution was added with p-nitrophenyl palmitate, and the pH value was adjusted to 4.5 with an 8 wt% acetic acid solution. After magnetic stirring for 40 minutes, the pH value was adjusted to 6.5 with a 12 wt% sodium hydroxide solution. Glutamine transaminase was added for solidification at 5°C for 2 hours. The mixture was freeze-dried in a vacuum and crushed to obtain Chinese medicine microcapsules. Example 3
[0058] A pharmaceutical composition for treating lung cancer, the pharmaceutical composition being prepared from the following raw materials in parts by weight: 15 parts of Prunella Vulgaris, 10 parts of Hedyotis diffusa, 10 parts of Agrimoniae, 18 parts of Cornus officinalis, 7 parts of Rutaceae, 6 parts of Solanum nigrum, 10 parts of Elsholtzia ciliata, 10 parts of Scutellaria baicalensis seeds, 6 parts of Scutellaria barbata, 8 parts of Astragalus, 3 parts of Cordyceps sinensis, 5 parts of Codonopsis pilosula, 10 parts of Atractylodes macrocephala, and 8 parts of Pinellia ternata;
[0059] The pharmaceutical composition comprises a traditional Chinese medicine extract and traditional Chinese medicine microcapsules;
[0060] The content of Chinese medicine microcapsules is 10% of the total mass of the Chinese medicine extract;
[0061] The Chinese medicine extract is obtained by decocting and filtering Elsholtzia ciliata, Scutellaria barbata, Astragalus membranaceus, Cordyceps sinensis, Codonopsis pilosula, Atractylodes macrocephala and Pinellia ternata;
[0062] The specific steps include:
[0063] According to weight, the herb Elsholtzia ciliata, the seed of Scutellaria baicalensis, the herb Scutellaria barbata, the root of Astragalus membranaceus, the herb Cordyceps sinensis, the herb Codonopsis pilosula, the herb Atractylodes macrocephala, and the herb Pinellia ternata are mixed and crushed, and then decocted with water. The decoction is then filtered and the filtrate is concentrated to a concentrate with a relative density of 1.4. The mixture is refrigerated and centrifuged, and the supernatant is taken and added with Chinese medicine microcapsules. The mixture is thoroughly mixed to obtain a pharmaceutical composition.
[0064] The preparation method of Chinese medicine microcapsules is as follows:
[0065] 1) Weigh a traditional Chinese medicine compound consisting of Prunella Vulgaris, Hedyotis Diffusa, Agrimoniae, Cornus officinalis, Rutaceae, and Solanum nigrum. Add 8 times the weight of distilled water to the compound, boil for 2 h, and filter to obtain a medicinal solution. Add 8 times the weight of distilled water to the medicinal residue, continue boiling for 2 h, and filter to obtain a medicinal solution. Combine the two medicinal solutions, filter, and concentrate in a 78°C oven to dry to obtain a concentrated Chinese medicine solution.
[0066] 2) Adding the Chinese herbal medicine concentrate to the MRS liquid medium at a rate of 3 wt% based on the mass of the liquid medium, mixing thoroughly to obtain a Chinese herbal medicine culture medium, and then activating Lactobacillus plantarum at an inoculum rate of 3% and inoculating the activated Lactobacillus plantarum into the Chinese herbal medicine culture medium under sterile conditions. The culture is then incubated at 39°C for 30 hours to obtain a Chinese herbal medicine fermentation broth.
[0067] 3) Mix 300 g of Chinese medicine, 9 mL of fermentation liquid of Chinese medicine strain, and 96 mL of water, stir and place in a breathing bag, compact and perform anaerobic fermentation of raw material in an incubator at 39°C for 80 hours. After the fermentation is completed, sterilize the fermented material at 123°C for 20 minutes and set aside.
[0068] The Chinese medicine is composed of Prunella Vulgaris, Hedyotis diffusa, Agrimony Root, Cornus officinalis, Rutaecarpa, and Solanum nigrum according to parts by weight;
[0069] 4) The fermentation product was centrifuged and filtered, and the filtrate was concentrated to a relative density of 1.3. Anhydrous ethanol was added, and the volume content of anhydrous ethanol was maintained at 90%. Then, water bath reflux extraction was performed for 70 minutes. After the reflux was completed, the product was repeatedly rinsed with anhydrous ethanol. Anhydrous ethanol was then added to the filtrate, and the volume content of anhydrous ethanol was maintained at 90%. Water bath reflux extraction was performed again for 70 minutes.
[0070] 5) Place the precipitates obtained from the two reactions in a container, add 180 mL of purified water, reflux in a water bath for 60 minutes, remove and cool to room temperature, centrifuge at 8000 rpm for 20 minutes, and collect the supernatant to obtain the traditional Chinese medicine solution;
[0071] 6) Gelatin and sodium carboxymethyl cellulose were dissolved in ultrapure water and stirred in a 70°C water bath for 3 hours. The mixture was centrifuged at 12,000 rpm and 6°C for 30 minutes. The mass ratio of gelatin to sodium carboxymethyl cellulose was 1:2, and a 1.5 wt% polymer wall material solution was obtained. The Chinese medicine solution was added to the polymer wall material solution according to a core-wall mass ratio of 1:5. 4% of the total mass of the polymer wall material solution was added with p-nitrophenyl palmitate, and the pH value was adjusted to 4.5 with a 10 wt% acetic acid solution. After magnetic stirring for 50 minutes, the pH value was adjusted to 6.5 with a 15 wt% sodium hydroxide solution. Glutamine transaminase was added for solidification at 6°C for 3 hours. The mixture was freeze-dried in a vacuum and crushed to obtain Chinese medicine microcapsules.
[0072] Comparative Example 1: This comparative example is basically the same as Example 1, except that it does not contain Chinese medicine microcapsules.
[0073] Comparative Example 2: This comparative example is basically the same as Example 1, except that step 2) is omitted in the preparation of the Chinese medicine microcapsules.
[0074] Comparative Example 3: This comparative example is basically the same as Example 1, except that, in the preparation of the Chinese medicine microcapsules, steps 2) to 3) are omitted.
[0075] Comparative Example 4: This comparative example is basically the same as Example 1, except that, in the preparation of the Chinese medicine microcapsules, the gelatin in step 6) is omitted.
[0076] Comparative Example 5: This comparative example is basically the same as Example 1, except that, in the preparation of the Chinese medicine microcapsules, sodium carboxymethyl cellulose in step 6) is omitted.
[0077] In vivo anti-tumor experiment in mice
[0078] 1. Experimental Methods
[0079] Several C57BL / 6J mice were taken and housed separately. The experiment was started after acclimating to the environment for 3 days. Lewis lung cancer cells of mice in the logarithmic growth phase were digested with trypsin, centrifuged, the supernatant was removed, and the cells were counted. The cell concentration was adjusted to 2×10 7 Lewis lung cancer cells were inoculated subcutaneously in the right forelimb axilla of mice at a dose of 0.1 mL / mouse to obtain tumor-bearing mice, and the first day of inoculation was recorded. The long diameter, short diameter, and body weight of the tumor were recorded every two days. When the tumor grew to 100 mm 3 The animals were randomly divided into 9 groups, with 6 animals in each group: (1) Control group: gavage with normal saline at a dose of 0.2 ml / animal; (2) Example 1 group: intraperitoneal injection of the pharmaceutical composition of Example 1 at 20 mg / kg; (3) Example 2 group: intraperitoneal injection of the pharmaceutical composition of Example 2 at 20 mg / kg; (4) Example 3 group: intraperitoneal injection of the pharmaceutical composition of Example 3 at 20 mg / kg; (5) Comparative Example 1 group: intraperitoneal injection of the pharmaceutical composition of Comparative Example 1 at 20 mg / kg; (6) Comparative Example 2 group: intraperitoneal injection of the pharmaceutical composition of Comparative Example 2 at 20 mg / kg; (7) Comparative Example 3 group: intraperitoneal injection of the pharmaceutical composition of Comparative Example 3 at 20 mg / kg; (8) Comparative Example 4 group: intraperitoneal injection of the pharmaceutical composition of Comparative Example 4 at 20 mg / kg; (9) Comparative Example 5 group: intraperitoneal injection of the pharmaceutical composition of Comparative Example 5 at 20 mg / kg.
[0080] Each group was given the drug continuously for 15 days. The next day after drug withdrawal, the mice were weighed, anesthetized, blood was collected, and the tumor-bearing mice were killed. The tumor was completely removed, and non-tumor tissues such as blood stains and fat were removed. The tumor was weighed and the tumor growth inhibition rate was calculated. Tumor growth inhibition rate (%) = (1-average tumor weight of the drug-dosing group (Example 1 group / Example 2 group / Example 3 / Comparative Example 1 group / Comparative Example 2 group / Comparative Example 3 group / Comparative Example 4 group / Comparative Example 5 group) / average tumor weight of the control group) × 100%. The spleen index and thymus index of the tumor-bearing mice were then measured: after killing the tumor-bearing mice, the spleen and thymus were removed, and the organ index was calculated after weighing. Organ index = organ weight (mg) / animal body weight (g).
[0081] 2. Experimental Results
[0082] After 15 days of administration of normal saline, Example 1, Example 2, Example 3, Comparative Example 1, Comparative Example 2, Comparative Example 3, Comparative Example 4, and Comparative Example 5 to tumor-bearing mice, the tumors were inhibited to varying degrees. The specific data are shown in Table 1:
[0083] Table 1 Results of tumor inhibition rates of different groups on tumor-bearing mice
[0084]
[0085] After killing the tumor-bearing mice, the spleen and thymus were dissected and the organ index was calculated. See Table 2 for details:
[0086] Table 2 Effects of different drugs on immune organ indexes in tumor-bearing mice
[0087]
[0088] From the above experimental results, it can be seen that in the anti-tumor experiment in mice, after administration to tumor-bearing mice, the pharmaceutical composition of Examples 1-3 of the present invention has a good tumor inhibition effect and has little effect on immune organs, and is an ideal anti-lung cancer drug.
[0089] The preferred embodiments of the present invention disclosed above are intended only to help illustrate the present invention. These preferred embodiments do not exhaustively describe all details, nor do they limit the present invention to the specific embodiments described. Obviously, many modifications and variations are possible based on the content of this specification. These embodiments are selected and described in detail in this specification to better explain the principles and practical applications of the present invention, thereby enabling those skilled in the art to better understand and utilize the present invention. The present invention is limited only by the claims and their full scope and equivalents.
Claims
1. A pharmaceutical composition for treating lung cancer, It is characterized in that The pharmaceutical composition is prepared from the following raw materials in parts by weight: 10-15 parts of Prunella Vulgaris, 5-10 parts of Oldenlandia Diffusa, 5-10 parts of Agrimoniae, 10-18 parts of Cornus officinalis, 3-7 parts of Rue Herba, 2-6 parts of Solanum nigrum, 5-10 parts of Elsholtzia ciliata, 5-10 parts of Gastrodia elatae, 3-6 parts of Scutellaria barbata, 2-8 parts of Astragalus, 1-3 parts of Cordyceps sinensis, 1-5 parts of Codonopsis pilosula, 2-10 parts of Atractylodes macrocephala, and 3-8 parts of Pinellia ternata.
2. The pharmaceutical composition for preventing lung cancer according to claim 1, characterized in that the pharmaceutical composition comprises a Chinese medicine extract and a Chinese medicine microcapsule; The content of the Chinese medicine microcapsules is 5-10% of the total mass of the Chinese medicine extract; The Chinese medicine extract is obtained by decocting and filtering Elsholtzia ciliata, Gastrodia elata, Scutellaria barbata, Astragalus, Cordyceps sinensis, Codonopsis pilosula, Atractylodes macrocephala and Pinellia ternata; The preparation method of the Chinese medicine microcapsule is as follows: 1.1) Mix 200-300g of Chinese medicine, 4-9mL of fermented liquid of Chinese medicine strains and 91-96mL of water evenly, stir and put into a breathing bag, compact and carry out anaerobic fermentation of raw materials in an incubator at 37-39℃ for 72-80h. After the fermentation is completed, sterilize the fermented material at 121-123℃ for 15-20min and set aside; 1.2) The fermented product is centrifuged and filtered, and the filtrate is concentrated to a relative density of 1.1-1.3, and anhydrous ethanol is added, and the volume content of anhydrous ethanol is maintained at 80-90%, and then water bath reflux extraction is performed. After the reflux is completed, it is repeatedly rinsed with anhydrous ethanol, and then anhydrous ethanol is added to the filtrate, and the volume content of anhydrous ethanol is maintained at 80-90%, and then water bath reflux extraction is performed again; 1.3) Put the precipitates obtained twice into a container, add 100-180 mL of purified water, reflux in a water bath for 40-60 min, take out and cool to room temperature, centrifuge at 5000-8000 r / min for 10-20 min, take the supernatant and obtain the Chinese medicine solution; 1.4) Dissolve gelatin and sodium carboxymethyl cellulose in ultrapure water, stir in a water bath at 60-70°C for 2-3h, centrifuge at 8000-12000r / min and 4-6°C for 20-30min to obtain a polymer wall material solution, add the Chinese medicine solution to the polymer wall material solution according to a core-wall mass ratio of 1:(4-5), add 2-4% of the total mass of the polymer wall material solution with p-nitrophenyl palmitate, and adjust the pH value to 4.0-4.5 with a 5-10wt% acetic acid solution, stir magnetically for 30-50min, adjust the pH value to 6.0-6.5 with a 10-15wt% sodium hydroxide solution, add glutamine aminotransferase at 4-6°C for solidification for 1-3h, freeze-dry in vacuum, and crush to obtain Chinese medicine microcapsules; In step 1.1), the Chinese medicine is composed of Prunella Vulgaris, Hedyotis diffusa, Agrimonia, Cornus officinalis, Rutaecarpa, and Solanum nigrum according to weight parts; The method for cultivating the Chinese medicinal strain fermentation liquid is as follows: 2.1) Weigh a compound Chinese medicine composed of Prunella Vulgaris, Hedyotis diffusa, Agrimoniae, Cornus officinalis, Rue herb, Solanum nigrum, etc., add 5-8 times the weight of distilled water of the compound Chinese medicine, decoct for 1-2 hours, filter to obtain a medicinal solution, add 5-8 times the weight of distilled water to the medicinal residue, continue to decoct for 1-2 hours, filter to obtain a medicinal solution, combine the two medicinal solutions and filter, put into an oven for concentration and drying, and obtain a Chinese medicine concentrate; 2.2) Add the Chinese medicine concentrate to the MRS liquid culture medium at 2-3wt% of the mass of the liquid culture medium, mix well to obtain the Chinese medicine culture medium, then activate the plant lactobacillus at an inoculation rate of 2-3%, inoculate it into the Chinese medicine culture medium under sterile conditions, and cultivate it for 24-30 hours to obtain the Chinese medicine strain fermentation liquid.
3. The anti-lung cancer pharmaceutical composition according to claim 2, It is characterized in that In step 1.2), the extraction time of the water bath reflux extraction is 50-70 minutes.
4. The anti-lung cancer pharmaceutical composition according to claim 2, It is characterized in that In step 1.4), the mass ratio of gelatin to sodium carboxymethyl cellulose is 1:(1-2); The concentration of the composite wall material solution is 0.5-1.5wt%.
5. The anti-lung cancer pharmaceutical composition according to claim 2, It is characterized in that In step 2.1), the temperature of the oven is 75-78°C.
6. The anti-lung cancer pharmaceutical composition according to claim 2, It is characterized in that In step 2.2), the incubation is performed at 37-39°C.
7. A method for preparing an anti-lung cancer pharmaceutical composition according to any one of claims 1 to 6, It is characterized in that The specific steps include: According to weight, Herba Elsholtziae, Semen Gastrodiae, Scutellariae Barbatae, Astragalus, Cordyceps, Codonopsis, Atractylodes, and Pinellia are mixed and crushed, and then water is added for decoction. The decoction is then filtered and the filtrate is concentrated to a concentrate with a relative density of 1.2-1.
4. The concentrate is refrigerated and then centrifuged. The supernatant is taken, Chinese medicine microcapsules are added, and the mixture is fully mixed to obtain a pharmaceutical composition.
Citation Information
Patent Citations
Pharmaceutical composition with anti-lung cancer effect and preparation method thereof
CN109010569A
Traditional Chinese medicine composition for auxiliary treatment of stage II silicosis and preparation method thereof
CN107998238A
Traditional Chinese medicine composition for inhibiting liver cancer and application thereof
CN109865050A
